The Board of Directors at their meeting held on 29th November 2024 have, inter alia, approved a preferential allotment for consideration other than cash, shifting of registered office, amalgamation, postal ballot notice and entered into a merger framework agreement ('MFA'), Shareholders' Agreement (SHA) and certain other agreements in relation to foregoing matters. Kindly take the above said information on record. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to Intimate the receipt of Competition Commission of India ('CCI') approval. We request you to kindly take the above information on record. (As Per Bse Announcement Dated on 16.04.2025) Intimation of receipt of no objection letters from Stock Exchanges (As per BSE Announcement dated on: 06.10.2025) Receipt of NCLT order dated January 21, 2026 (As per BSE Announcement dated on: 22.01.2026). We wish to inform you regarding the order passed by the Honble NCLT, Hyderabad Bench, approving the Scheme of Amalgamation. (As per BSE announcement dated on : 19.06.2026) The Company has received the Certified true copy of the order passed by the Honble NCLT, Hyderabad Bench, approving the scheme of Amalgamation (As Per BSE Announcement Dated on 24.06.2026) Board Meeting Outcome for Taking Note Of NCLT Order And Fixing Of Record Date (As Per BSE Announcement Dated on: 25/06/2026). Update on Scheme of Amalgamation of the Company with regard to Effective Date of the Scheme, change in promoter category, and amended MOA & AOA. (As per BSE announcement dated on : 01.07.2026) Allotment of equity shares to the shareholders of Transferor Company (QCIL) pursuant to the Scheme of Amalgamation (As Per BSE Announcement Dated on 13.07.2026)